Delivery Order SPE2DX22D0010-SPE2D825FDJ39
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$2.8K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.00 firm fixed-price delivery order is for the supply of 4566779797 - Oxymorphone HCL ER 20 MG Tablets in 60-count packages. The contract has a completion date of December 23, 2024. This award is associated with Amerisourcebergen's...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.49 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 24, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,327.10 delivery order contract is for the supply of 30mg Oxymorphone HCL ER tablets, a pain management medication. The contract has an August 2023 completion date and is a firm fixed-price arrangement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,672.25, is a firm fixed price delivery order for 4,564,082,819 units of Oxymorphone Hydrochloride Extended-Release Tablets 40mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,417.79, is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of February 4, 2025. The contract is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $7,904.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of 4566006917 - Oxymorphone HCL ER Tabs 20mg, a prescription pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is October 3, 2024. The contract was awarded on October 2, 2024 and does...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of OXYMORPHONE HCL ER 5 MG TABLET 60S, a specialty pharmaceutical product. The award has a ceiling value of $2,287.02 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,634.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of oxymorphone hydrochloride extended-release tablets, a pain management medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for Oxymorphone HCL ER Tablets 30mg. The $7,186.27 firm fixed-price contract has an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,629.87, is for the delivery of Oxymorphone Hydrochloride Extended-Release Tablets, 20mg. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price type. The contract is not designated as a set-aside. AmerisourceBergen holds a...